Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
65.49
+3.55 (5.73%)
May 22, 2026, 4:00 PM EDT - Market closed

Haemonetics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
2,9762,4453,0474,3354,1753,264
Market Cap Growth
-12.89%-19.74%-29.71%3.84%27.89%-42.73%
Enterprise Value
4,0053,4253,9654,9644,6563,778
Last Close Price
65.4954.0463.1985.3582.7563.85
PE Ratio
31.9526.3619.0937.2736.9476.01
Forward PE
12.5410.4613.2120.4925.4523.82
PEG Ratio
1.160.961.001.392.421.36
PS Ratio
2.231.832.243.313.573.29
PB Ratio
3.723.073.714.525.104.36
P/TBV Ratio
3.893.213.914.575.204.38
P/FCF Ratio
11.439.3921.3930.1851.0843.09
P/OCF Ratio
10.158.3416.7723.8515.2918.95
EV/Sales Ratio
3.002.572.913.793.983.80
EV/EBITDA Ratio
11.2112.7611.7518.9418.6721.17
EV/EBIT Ratio
15.9221.8517.8730.1029.8446.79
EV/FCF Ratio
15.3813.1527.8334.5656.9749.88
Debt / Equity Ratio
1.541.541.490.840.941.03
Debt / EBITDA Ratio
4.564.563.633.083.074.33
Debt / FCF Ratio
4.704.708.605.629.3710.21
Net Debt / Equity Ratio
1.231.231.120.660.590.69
Net Debt / EBITDA Ratio
3.653.652.722.401.932.88
Net Debt / FCF Ratio
3.763.766.454.385.896.79
Asset Turnover
0.550.550.590.630.620.54
Inventory Turnover
1.741.631.792.142.001.58
Quick Ratio
1.641.640.881.281.840.95
Current Ratio
2.952.951.622.563.061.71
Return on Equity (ROE)
11.40%12.03%18.83%13.22%14.72%5.86%
Return on Assets (ROA)
4.88%4.92%7.55%6.18%6.71%2.99%
Return on Invested Capital (ROIC)
5.87%5.88%9.04%7.54%8.45%3.64%
Return on Capital Employed (ROCE)
7.71%7.86%11.77%9.22%10.07%5.41%
Earnings Yield
3.27%3.79%5.24%2.68%2.71%1.32%
FCF Yield
8.75%10.65%4.68%3.31%1.96%2.32%
Buyback Yield / Dilution
6.65%6.65%1.30%0.04%-0.13%-0.12%
Total Shareholder Return
6.65%6.65%1.30%0.04%-0.13%-0.12%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q